Literature DB >> 18086847

Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis.

Richard Colgan1, James R Johnson, Michael Kuskowski, Kalpana Gupta.   

Abstract

Emerging antimicrobial resistance among uropathogens makes the management of acute uncomplicated cystitis increasingly challenging. Few prospective data are available on the risk factors for resistance to trimethoprim-sulfamethoxazole (TMP-SMX), the drug of choice in most settings. In order to evaluate this, we prospectively enrolled women 18 to 50 years of age presenting to an urban primary care practice with symptoms of cystitis. Potentially eligible women provided a urine sample for culture and completed a questionnaire regarding putative risk factors for TMP-SMX resistance. Escherichia coli isolates were tested for clonal group A (CGA) membership by a fumC-specific PCR. Of 165 women with cystitis symptoms, 103 had a positive urine culture and were eligible for participation. E. coli was the predominant uropathogen (86%). Fifteen (14.6%) women had a TMP-SMX-resistant (TMP-SMX r) organism (all of which were E. coli). Compared with the women who had a TMP-SMX-susceptible organism, women in the TMP-SMX r group were more likely to have traveled (odds ratio [OR], 15.4; 95% confidence interval [CI], 4.4 to 54.3; P < 0.001) and to be Asian (OR, 6.1; 95% CI, 1.0 to 36.4; P = 0.048). CGA was also independently associated with TMP-SMX resistance (OR, 105; 95% CI, 6.3 to 1,777.6; P = 0.001). No association with TMP-SMX resistance was demonstrated for the use of either TMP-SMX or another antibiotic in the past 3 months or with having a child in day care. Among these women with acute uncomplicated cystitis, Asian race and recent travel were independently associated with TMP-SMX resistance. TMP-SMX r isolates were more likely to belong to CGA. Knowledge of these risk factors for TMP-SMX resistance could facilitate the accurate selection of empirical therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18086847      PMCID: PMC2258492          DOI: 10.1128/AAC.01200-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy.

Authors:  Thomas M Hooton; Richard Besser; Betsy Foxman; Thomas R Fritsche; Lindsay E Nicolle
Journal:  Clin Infect Dis       Date:  2004-06-14       Impact factor: 9.079

2.  Risk stratification for trimethoprim-sulfamethoxazole resistance in community-acquired, uncomplicated urinary tract infections.

Authors:  Philippe A Mentler; Bryan R Kuhn; Guneet Gandhi
Journal:  Am J Health Syst Pharm       Date:  2006-09-01       Impact factor: 2.637

3.  When do general practitioners request urine specimens for microbiology analysis? The applicability of antibiotic resistance surveillance based on routinely collected data.

Authors:  Sharon Hillier; Joanna Bell; Margaret Heginbothom; Zoë Roberts; Frank Dunstan; Anthony Howard; Brendan Mason; Christopher C Butler
Journal:  J Antimicrob Chemother       Date:  2006-10-24       Impact factor: 5.790

4.  Current antibiotic therapy for isolated urinary tract infections in women.

Authors:  Alexander J Kallen; H Gilbert Welch; Brenda E Sirovich
Journal:  Arch Intern Med       Date:  2006-03-27

5.  The rise and fall of Escherichia coli O15 in a London teaching hospital.

Authors:  P M O'Neill; C A Talboys; A P Roberts; B S Azadian
Journal:  J Med Microbiol       Date:  1990-09       Impact factor: 2.472

6.  Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis.

Authors:  Kalpana Gupta; Thomas M Hooton; Walter E Stamm
Journal:  J Antimicrob Chemother       Date:  2005-05-23       Impact factor: 5.790

7.  Antibiotic resistance of urinary pathogens in female general practice patients.

Authors:  Eva Hummers-Pradier; Matthias Koch; Ann Marit Ohse; Wolfgang R Heizmann; Michael M Kochen
Journal:  Scand J Infect Dis       Date:  2005

8.  Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates.

Authors:  William J Burman; Peter E Breese; Barbara E Murray; Kavindra V Singh; Holly A Batal; Thomas D MacKenzie; John W Ogle; Michael L Wilson; Randall R Reves; Philip S Mehler
Journal:  Am J Med       Date:  2003-10-01       Impact factor: 4.965

9.  Predictors of antimicrobial-resistant Escherichia coli in the feces of vegetarians and newly hospitalized adults in Minnesota and Wisconsin.

Authors:  Mark R Sannes; Edward A Belongia; Burney Kieke; Kirk Smith; Amy Kieke; Mary Vandermause; Jeff Bender; Connie Clabots; Patricia Winokur; James R Johnson
Journal:  J Infect Dis       Date:  2008-02-01       Impact factor: 5.226

10.  Distribution and characteristics of Escherichia coli clonal group A.

Authors:  James R Johnson; Andrew C Murray; Michael A Kuskowski; Sören Schubert; Marie-Francoise Prère; Bertrand Picard; Raul Colodner; Raul Raz
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

View more
  19 in total

1.  Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death.

Authors:  Robert C Owens; James R Johnson; Patricia Stogsdill; Lonny Yarmus; Karen Lolans; John Quinn
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

2.  Oral consumption of cranberry juice cocktail inhibits molecular-scale adhesion of clinical uropathogenic Escherichia coli.

Authors:  Yuanyuan Tao; Paola A Pinzón-Arango; Amy B Howell; Terri A Camesano
Journal:  J Med Food       Date:  2011-04-11       Impact factor: 2.786

3.  Escherichia coli sequence type 73 as a cause of community acquired urinary tract infection in men and women in Rio de Janeiro, Brazil.

Authors:  Ana Paula de Souza da-Silva; Viviane Santos de Sousa; Natacha Martins; Rubens Clayton da Silva Dias; Raquel Regina Bonelli; Lee W Riley; Beatriz Meurer Moreira
Journal:  Diagn Microbiol Infect Dis       Date:  2017-02-07       Impact factor: 2.803

4.  Analysis of urine-specific antibiograms from veterans to guide empiric therapy for suspected urinary tract infection.

Authors:  Ketzela J Marsh; Lesley Mundy; John J Holter; James R Johnson
Journal:  Diagn Microbiol Infect Dis       Date:  2019-07-30       Impact factor: 2.803

5.  Has the emergence of community-associated methicillin-resistant Staphylococcus aureus increased trimethoprim-sulfamethoxazole use and resistance?: a 10-year time series analysis.

Authors:  Jameson B Wood; Donald B Smith; Errol H Baker; Stephen M Brecher; Kalpana Gupta
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

6.  Risk factors for antimicrobial resistance among the Escherichia coli strains isolated from Korean patients with acute uncomplicated cystitis: a prospective and nationwide study.

Authors:  Gilho Lee; Yong-Hyun Cho; Bong Suk Shim; Sang Don Lee
Journal:  J Korean Med Sci       Date:  2010-07-21       Impact factor: 2.153

7.  Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy.

Authors:  Michael A Liss; Ellena M Peterson; Brian Johnston; Kathryn Osann; James R Johnson
Journal:  Urology       Date:  2013-01-17       Impact factor: 2.649

8.  Antibiotic-resistant Escherichia coli in women with acute cystitis in Canada.

Authors:  Warren J McIsaac; Rahim Moineddin; Christopher Meaney; Tony Mazzulli
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

9.  Association between antimicrobial consumption and resistance in Escherichia coli.

Authors:  Miika Bergman; Solja T Nyberg; Pentti Huovinen; Pirkko Paakkari; Antti J Hakanen
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

10.  Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals.

Authors:  Li-Yang Hsu; Thean-Yen Tan; Vincent H Tam; Andrea Kwa; Dale Andrew Fisher; Tse-Hsien Koh
Journal:  Antimicrob Agents Chemother       Date:  2010-01-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.